BR9815501A - Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma - Google Patents

Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma

Info

Publication number
BR9815501A
BR9815501A BR9815501-6A BR9815501A BR9815501A BR 9815501 A BR9815501 A BR 9815501A BR 9815501 A BR9815501 A BR 9815501A BR 9815501 A BR9815501 A BR 9815501A
Authority
BR
Brazil
Prior art keywords
glaucoma
treatment
side effects
prostaglandin derivatives
derivatives free
Prior art date
Application number
BR9815501-6A
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Staffan Lake
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9815501(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of BR9815501A publication Critical patent/BR9815501A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<B>"DERIVADOS DE PROSTAGLANDINA ISENTOS DE EFEITOS COLATERAIS PARA O TRATAMENTO DE GLAUCOMA"<D>. A invenção descreve um novo método e composições para o tratamento de glaucoma e hipertensão ocular. O método se baseia no uso de agonistas prostanóides receptores de EP~ 1~, que efetivamente reduzem a pressão intraocular, mas, que não apresentam qualquer efeito ou apenas um efeito reduzido sobre a pigmentação da íris. O análogo de prostaglandina que é um agonista seletivo de EP~ 1~ é aplicado topicamente sobre o olho.
BR9815501-6A 1997-07-11 1998-07-10 Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma BR9815501A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702706A SE9702706D0 (sv) 1997-07-11 1997-07-11 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
PCT/SE1998/001368 WO1999002165A1 (en) 1997-07-11 1998-07-10 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
BR9815501A true BR9815501A (pt) 2001-07-17

Family

ID=20407743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815501-6A BR9815501A (pt) 1997-07-11 1998-07-10 Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma

Country Status (19)

Country Link
EP (1) EP1014991A1 (pt)
JP (1) JP2002509543A (pt)
KR (1) KR20010021682A (pt)
CN (1) CN1169528C (pt)
AU (1) AU739828B2 (pt)
BR (1) BR9815501A (pt)
CA (1) CA2294779A1 (pt)
HK (1) HK1029942A1 (pt)
HU (1) HUP0003106A3 (pt)
IL (1) IL133871A (pt)
IS (1) IS5333A (pt)
NO (1) NO20000062D0 (pt)
NZ (1) NZ501834A (pt)
PL (1) PL337940A1 (pt)
RU (1) RU2207858C2 (pt)
SE (1) SE9702706D0 (pt)
SK (1) SK183499A3 (pt)
TR (1) TR200000008T2 (pt)
WO (1) WO1999002165A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
AU766163B2 (en) 1999-03-05 2003-10-09 Duke University C16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
AU2003299137A1 (en) * 2002-09-16 2004-04-23 Texas Tech University System Inhibition of metallo-beta-lactamase
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
EP2305304A4 (en) 2008-04-28 2011-08-10 Nat University Corp Hamamatsu University School Of Medicine IMMUNOSTIMULATOR WITH EP1 AGONIST
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
ES2672624T3 (es) 2009-05-01 2018-06-15 Aerie Pharmaceuticals, Inc. Inhibidores de mecanismo doble para el tratamiento de enfermedades
WO2011046569A1 (en) * 2009-10-16 2011-04-21 Cayman Chemical Company Process for the preparation of f-series prostaglandins
DK2831077T3 (en) 2012-03-28 2016-08-15 Merck Patent Gmbh BICYCLIC PYRAZINO DERIVATIVES
JP2012246301A (ja) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Ｆ系プロスタグランジン類を調製する方法
PL3811943T3 (pl) 2013-03-15 2023-06-12 Aerie Pharmaceuticals, Inc. Związek do stosowania w leczeniu zaburzeń oczu
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
JP6907319B2 (ja) 2016-08-31 2021-07-21 アエリエ ファーマシューティカルズ インコーポレイテッド 眼科用組成物
CA3057872A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.

Also Published As

Publication number Publication date
TR200000008T2 (tr) 2000-05-22
AU739828B2 (en) 2001-10-18
SE9702706D0 (sv) 1997-07-11
NZ501834A (en) 2002-05-31
NO20000062L (no) 2000-01-06
KR20010021682A (ko) 2001-03-15
AU8368398A (en) 1999-02-08
RU2207858C2 (ru) 2003-07-10
WO1999002165A1 (en) 1999-01-21
HK1029942A1 (en) 2001-04-20
HUP0003106A3 (en) 2002-12-28
HUP0003106A2 (hu) 2001-01-29
NO20000062D0 (no) 2000-01-06
CN1262623A (zh) 2000-08-09
SK183499A3 (en) 2000-07-11
IS5333A (is) 2000-01-07
IL133871A0 (en) 2001-04-30
IL133871A (en) 2004-09-27
CN1169528C (zh) 2004-10-06
EP1014991A1 (en) 2000-07-05
CA2294779A1 (en) 1999-01-21
PL337940A1 (en) 2000-09-11
JP2002509543A (ja) 2002-03-26

Similar Documents

Publication Publication Date Title
BR9815501A (pt) Derivados de prostaglandina isentos de efeitos colaterais para o tratamento de glaucoma
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
LU92509I2 (fr) Travoprost et ses dérivés pharmaceutiquement acceptables (TRAVATAN)
TWI255714B (en) Method for treating meibomian gland disease
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
AU5446299A (en) Medicinal compositions for treating eye diseases
ATE359794T1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
AU2001278708A1 (en) Adenosine derivatives and use thereof
BR0017163A (pt) Derivados 5-hidróxi-indazol para tratamento do glaucoma
WO2000038667A3 (en) Prostaglandin e agonists for treatment of glaucoma
HK1024170A1 (en) Remedial composition for intraocular hypertension or glaucoma
BR0017158A (pt) Agonistas de 5ht2 para controlar a iop e tratar o glaucoma
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
BR0215172A (pt) Derivados de benzodifuranimidazolina e benzofuranimidazolina e seu emprego para o tratamento de glaucoma
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
NO980058L (no) Opthalmiske preparater
PT1021184E (pt) Utilizacao de flunarizina para o tratamento topico da hipertensao ocular
SE0002211D0 (sv) Methods and compositions for prevention of myopia
ES2171742T3 (es) Agente reductor de la presion ocular.
EP1142576A4 (en) MEDICINAL COMPOSITION FOR TREATING THE INCREASED EYE PRESSURE OR GLAUCOMA
EP1300151A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU2002230135A1 (en) Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine A3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.